标题
Zoledronic Acid (Reclast®, Aclasta®): A Review in Osteoporosis
作者
关键词
Bone Mineral Density, Femoral Neck, Vertebral Fracture, Zoledronic Acid, Teriparatide
出版物
DRUGS
Volume 76, Issue 17, Pages 1683-1697
出版商
Springer Nature
发表日期
2016-11-18
DOI
10.1007/s40265-016-0662-4
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
- (2016) P. D. Miller et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study)
- (2016) T. Nakamura et al. OSTEOPOROSIS INTERNATIONAL
- The Effect of 6 versus 9 Years of Zoledronic Acid Treatment in Osteoporosis: A Randomized Second Extension to the HORIZON-Pivotal Fracture Trial (PFT)
- (2015) Dennis M. Black et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research: 2014 update
- (2014) Yasuo Suzuki et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Subgroup Variations in Bone Mineral Density Response to Zoledronic Acid After Hip Fracture
- (2014) Jay S Magaziner et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The Incidence of Osteonecrosis of the Jaw in Patients Receiving 5 Milligrams of Zoledronic Acid
- (2014) John T. Grbic et al. JOURNAL OF THE AMERICAN DENTAL ASSOCIATION
- Clinician’s Guide to Prevention and Treatment of Osteoporosis
- (2014) F. Cosman et al. OSTEOPOROSIS INTERNATIONAL
- Goal-directed treatment of osteoporosis in Europe
- (2014) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Diagnostic criteria for primary osteoporosis: year 2012 revision
- (2013) Satoshi Soen et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Randomized controlled trial of zoledronic acid for treatment of osteoporosis in women
- (2013) Hua Bai et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis
- (2013) M. Tadrous et al. OSTEOPOROSIS INTERNATIONAL
- Long-Term Effects of Amino-Bisphosphonates on Circulating γδ T Cells
- (2012) Maurizio Rossini et al. CALCIFIED TISSUE INTERNATIONAL
- Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: The HORIZON-Pivotal Fracture Trial (PFT)
- (2012) Richard M Jacques et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Fracture Risk and Zoledronic Acid Therapy in Men with Osteoporosis
- (2012) Steven Boonen et al. NEW ENGLAND JOURNAL OF MEDICINE
- A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis
- (2012) S. Lekamwasam et al. OSTEOPOROSIS INTERNATIONAL
- European guidance for the diagnosis and management of osteoporosis in postmenopausal women
- (2012) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Health-related quality of life and treatment of postmenopausal osteoporosis: Results from the HORIZON-PFT
- (2011) Philip N. Sambrook et al. BONE
- Bisphosphonates and glucocorticoid osteoporosis in men: results of a randomized controlled trial comparing zoledronic acid with risedronate
- (2011) Philip N. Sambrook et al. BONE
- The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)
- (2011) Dennis M Black et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Once-Yearly Zoledronic Acid in Older Men Compared with Women with Recent Hip Fracture
- (2011) Steven Boonen et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Antiresorptive therapies for osteoporosis: a clinical overview
- (2011) Jian Sheng Chen et al. Nature Reviews Endocrinology
- Zoledronic acid results in better health-related quality of life following hip fracture: the HORIZON–Recurrent Fracture Trial
- (2011) J. D. Adachi et al. OSTEOPOROSIS INTERNATIONAL
- Treatment with acetaminophen/paracetamol or ibuprofen alleviates post-dose symptoms related to intravenous infusion with zoledronic acid 5 mg
- (2011) J. D. Wark et al. OSTEOPOROSIS INTERNATIONAL
- 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
- (2010) A. Papaioannou et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- The effects of intravenous zoledronic acid in Chinese women with postmenopausal osteoporosis
- (2010) Jawl-Shan Hwang et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: A randomized, multicenter, double-blind, active-controlled study
- (2010) Eric S Orwoll et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis
- (2010) Felicia Cosman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Once-yearly zoledronic acid and days of disability, bed rest, and back pain: Randomized, controlled HORIZON Pivotal Fracture Trial
- (2010) Jane A Cauley et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Characterization of and Risk Factors for the Acute-Phase Response after Zoledronic Acid
- (2010) I. R. Reid et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Antifracture Efficacy and Reduction of Mortality in Relation to Timing of the First Dose of Zoledronic Acid After Hip Fracture
- (2009) Erik Fink Eriksen et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Yearly Zoledronic Acid 5 mg on Bone Turnover Markers and Relation of PINP With Fracture Reduction in Postmenopausal Women With Osteoporosis
- (2009) Pierre D Delmas et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effect of Once-Yearly Zoledronic Acid Five Milligrams on Fracture Risk and Change in Femoral Neck Bone Mineral Density
- (2009) Richard Eastell et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial
- (2009) David M Reid et al. LANCET
- Zoledronic Acid for the Prevention of Bone Loss in Postmenopausal Women With Low Bone Mass
- (2009) Michael McClung et al. OBSTETRICS AND GYNECOLOGY
- Peripheral blood monocytes are responsible for γδ T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP
- (2008) Anke J. Roelofs et al. BRITISH JOURNAL OF HAEMATOLOGY
- Zoledronic Acid
- (2008) Emma D Deeks et al. DRUGS & AGING
- Renal safety of annual zoledronic acid infusions in osteoporotic postmenopausal women
- (2008) Steven Boonen et al. KIDNEY INTERNATIONAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started